Lazard Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,815
| Closed | -$123K | – | 2643 |
|
|
2022
Q3 | $123K | Buy |
+1,815
| New | +$123K | ﹤0.01% | 1401 |
|
|
2022
Q2 | – | Sell |
-2,579
| Closed | -$89K | – | 2648 |
|
|
2022
Q1 | $89K | Hold |
2,579
| – | – | ﹤0.01% | 1444 |
|
|
2021
Q4 | $75K | Buy |
2,579
+617
| +31% | +$17.9K | ﹤0.01% | 1554 |
|
|
2021
Q3 | $49K | Buy |
+1,962
| New | +$49K | ﹤0.01% | 1695 |
|
|
2021
Q1 | – | Sell |
-1,539
| Closed | -$66K | – | 2091 |
|
|
2020
Q4 | $66K | Buy |
+1,539
| New | +$66K | ﹤0.01% | 1307 |
|